Skip to content

Xeroderma Pigmentosum Group G C0268141

Published: July 22, 2026Updated: August 20, 2026

A rare severe form of a disorder that prevents DNA repair after UV exposure. Complete sun avoidance and regular cancer monitoring are essential.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q82.1
ICD-11
LA00.0
Body system
dermatologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(dermatologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Ultraviolet Radiation Avoidance

Comprehensive photoprotection protocol including broad-spectrum SPF 50+ sunscreen application every 2 hours during any potential exposure, wearing UV-protective garments, and use of UV meter to identify safe environments.

lifestyle
3

Ocular and Cutaneous Cancer Surveillance

Quarterly ophthalmologic examinations for UV-induced ocular damage and regular full-body skin examinations with dermoscopy to identify and biopsy suspicious lesions before malignant transformation.

monitoring

Additional treatment options

Antioxidant Nutritional Support

Dietary supplementation with antioxidants including vitamin C, vitamin E, and alpha-lipoic acid to potentially reduce oxidative DNA damage. Combined with vitamin D supplementation due to sun avoidance.

dietary

Topical Immunomodulator Therapy

Application of topical imiquimod or similar immunomodulatory agents to actinic lesions and areas of concern to stimulate local immune response against precancerous cells.

medication

Neurodegenerative Complication Screening

Periodic comprehensive neurological evaluation to detect early signs of XP-associated neurodegeneration, including hearing assessment, peripheral nerve studies, and cognitive testing.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Xeroderma Pigmentosum Group G C0268141?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kraemer KH, Tamura D, Khan SG. Xeroderma pigmentosum: emerging picture of a classic disorder. Nat Rev Dermatol. 2022.

review2022
2

Lehmann J, Schubert S, Emmert S. European guideline for diagnosis and management of xeroderma pigmentosum. Br J Dermatol. 2021.

guideline2021
3

Cleaver JE, Feeney L, Revet I. Phosphorylation of老大 ERCC5 in xeroderma pigmentosum group G cells. DNA Repair. 2019.

other2019
4

Scharer OD, Busch D, Heine A. Molecular analysis of ERCC5 mutations in xeroderma pigmentosum group G patients. J Invest Dermatol. 2020.

clinical_trial2020

Medication Comparisons

Compare medications used to treat Xeroderma Pigmentosum Group G C0268141. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy